Forte Biosciences, Inc. Common Stock

FBRX XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

1.1B

Short interest (Jul 15)

10.1%

Net Short (Jul 27 ): -1.7%

Borrow Fee

2.34%

↑ 25.1%

Available Shares

800K

↓ 31.0%

Price Chart

Company Overview

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001419041

Asset Type: CS

Market Data

Market Cap: $1,121,829,595

Employees: 22

Status: Active

Short Interest

Current Borrow Fee 2.34%

Range: 1.92% - 2.34%

Available Shares 800K

Range: 350K - 800K

Recent Changes

Fee Change: ↑ 47.2%

Available Change: ↑ 75.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime